berberine has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although several studies confirmed that berberine may attenuate airway inflammation in mice with chronic obstructive pulmonary disease (COPD), its underlying mechanisms were not clear until now." | 7.91 | Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway. ( Li, CN; Wang, W; Wang, X; Wu, XJ; Zha, G; Zou, JJ, 2019) |
| "Berberine (Ber) is an isoquinoline alkaloid that has shown therapeutic potential in mice with chronic obstructive pulmonary disease (COPD)." | 5.72 | Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats. ( Li, D; Li, Y; Liu, H; Shi, M; Wang, Y; Zhang, X, 2022) |
| "Although several studies confirmed that berberine may attenuate airway inflammation in mice with chronic obstructive pulmonary disease (COPD), its underlying mechanisms were not clear until now." | 3.91 | Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway. ( Li, CN; Wang, W; Wang, X; Wu, XJ; Zha, G; Zou, JJ, 2019) |
| "Berberine (Ber) is an isoquinoline alkaloid that has shown therapeutic potential in mice with chronic obstructive pulmonary disease (COPD)." | 1.72 | Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats. ( Li, D; Li, Y; Liu, H; Shi, M; Wang, Y; Zhang, X, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, H | 1 |
| Li, Y | 1 |
| Zhang, X | 1 |
| Shi, M | 1 |
| Li, D | 1 |
| Wang, Y | 1 |
| Wang, W | 1 |
| Zha, G | 1 |
| Zou, JJ | 1 |
| Wang, X | 1 |
| Li, CN | 1 |
| Wu, XJ | 1 |
2 other studies available for berberine and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Chitosan-Coated Solid Lipid Nano-Encapsulation Improves the Therapeutic Antiairway Inflammation Effect of Berberine against COPD in Cigarette Smoke-Exposed Rats.
Topics: Animals; Berberine; Chitosan; Cigarette Smoking; Cytokines; Humans; Inflammation; Lipids; Liposomes; | 2022 |
Berberine Attenuates Cigarette Smoke Extract-induced Airway Inflammation in Mice: Involvement of TGF-β1/Smads Signaling Pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Bronchoalveolar Lavage Fluid; Cigarette | 2019 |